These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3397652)

  • 1. Prospective management of malignant hyperthermia in the otolaryngological patient.
    Wackym PA; Abdul-Rasool IH
    J Laryngol Otol; 1988 Jun; 102(6):513-6. PubMed ID: 3397652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hyperthermia in the otolaryngologic patient: prospective anesthetic and surgical management of eight children.
    Dudley JP; Reynolds R; Dubrow TJ
    Ann Otol Rhinol Laryngol; 1990 Apr; 99(4 Pt 1):297-9. PubMed ID: 2327699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hyperthermia in the otology patient: the UCLA experience.
    Wackym PA; Blackwell KE
    Am J Otol; 1994 May; 15(3):371-5. PubMed ID: 8579142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia: experience in the prospective management of eight children.
    Dubrow TJ; Wackym PA; Abdul-Rasool IH; Moore TC
    J Pediatr Surg; 1989 Feb; 24(2):163-6. PubMed ID: 2724006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hyperthermia in plastic surgery.
    Wackym PA; Dubrow TJ; Abdul-Rasool IH; Lesavoy MA
    Plast Reconstr Surg; 1988 Nov; 82(5):878-82. PubMed ID: 3174876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurosurgery in the malignant hyperthermia-susceptible patient.
    Wackym PA; Dubrow TJ; Abdul-Rasool IH; Peacock WJ
    Neurosurgery; 1988 Jun; 22(6 Pt 1):1032-6. PubMed ID: 3419564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of otolaryngic patients susceptible to malignant hyperthermia without dantrolene.
    Derkay CS; Grundfast KM
    Otolaryngol Head Neck Surg; 1991 Nov; 105(5):680-6. PubMed ID: 1754251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anesthesia in malignant hyperthermia susceptible patients.
    Mauritz W; Hackl W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Belg; 1990; 41(2):87-94. PubMed ID: 1973553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of a patient with malignant hyperthermia susceptibility during anesthesia and daily living].
    Jacquot C; Stieglitz P
    Ann Fr Anesth Reanim; 1989; 8(5):417-26. PubMed ID: 2697156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hyperthermia: a review.
    Johnson C; Edleman KJ
    J Perinatol; 1992 Mar; 12(1):61-71. PubMed ID: 1560293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
    Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA
    Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant hyperthermia in Austria. III. Anesthesia in susceptible patients].
    Mauritz W; Hackl W; Sporn P; Steinbereithner K
    Anaesthesist; 1988 Aug; 37(8):522-8. PubMed ID: 3177878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia in the oral and maxillofacial surgery patient: an update.
    Patil PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):e1-7. PubMed ID: 21827956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hyperthermia.
    Rosenberg H; Davis M; James D; Pollock N; Stowell K
    Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of malignant hyperthermia crisis].
    Cornet C; Moeller R; Laxenaire MC
    Ann Fr Anesth Reanim; 1989; 8(5):435-43. PubMed ID: 2516711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
    Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
    Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility.
    Allen GC; Rosenberg H; Fletcher JE
    Anesthesiology; 1990 Apr; 72(4):619-22. PubMed ID: 2321777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant Hyperthermia Susceptibility and Fitness for Duty.
    Lee MA; McGlinch EB; McGlinch MC; Capacchione JF
    Mil Med; 2017 Mar; 182(3):e1854-e1857. PubMed ID: 28290972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hyperthermia.
    Ben Abraham R; Adnet P; Glauber V; Perel A
    Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.
    O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE
    Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.